Mouse monoclonal [CIa] to Ia Antigen (Biotin) ( Abpromise for all tested applications)....
Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...
Mouse monoclonal [15-2] to Mannose Receptor (Biotin) ( Abpromise for all tested applications). entrezGeneID: 4360 SwissProtID: P22897...
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Biology Products:(Date:12/3/2009)... Rapids, Mich. (Dec. 3, 2009) Van Andel ... hormone abscisic acid (ABA) works at the molecular level to ... cold. Their findings, published in the journal Nature ... around the world and combat global food shortages. The ...
(Date:12/3/2009)... by a social snubbing? Your genetics, not your friends, may ... painkillers, called opioids, relieve not only physical pain, but also ... by Faculty of 1000 Biology member Markus Heilig shows that ... can determine the intensity of people,s responses to social rejection. ...
(Date:12/3/2009)... the past three years in the troposphere (lower atmosphere) ... results, which are the first of their kind in ... between 2002 and 2005. , Over recent years, physicists ... carbon dioxide (CO2) levels, and how these have evolved ...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3CO2 levels rising in troposphere over rural areas 2SynergEyes Inc Launches New Hybrid Lens Design for Keratoconus Patients 52100 1SynergEyes Inc Launches New Hybrid Lens Design for Keratoconus Patients 52100 2SynergEyes Inc Launches New Hybrid Lens Design for Keratoconus Patients 52100 3Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 1Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 2Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 3New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 1New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 2New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 3New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 4New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 5New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 6(Date:12/4/2009)... and Technology (NIST) and the Naval Research Laboratory have ... a semiconductor crystal by prodding it with a scanning ... technique will enable researchers to selectively implant atoms in ... its electrical and magnetic properties on the atomic scale. ...
(Date:12/4/2009)... Inc. (OTC Bulletin Board: BFRE), a company focused on changing ... from non-food cellulosic wastes, has been ranked number 19 on ... Companies in Bioenergy;" the company,s second consecutive year in the ... the top 20 bioenergy companies for two straight years is ...
(Date:12/3/2009)... 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), ... for the treatment of cardiovascular and metabolic disease, today ... in its Phase 2 FDG-PET clinical trial of VIA-2291. ... was carried out at five sites in the US ...
(Date:12/3/2009)... HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. ... and services for drug discovery and life sciences research, ... vivo imaging systems. Living Image software drives the more ... worldwide. Living Image 4.0 features advanced spectral unmixing tools ...
Breaking Biology Technology:NIST researchers put a new spin on atomic musical chairs 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2